Evidence map›Paper›PMID 30114393›Full record

ArticleContraception2019

Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder.

Anupama Kotha, Beatrice A Chen, Lauren Lewis, Shannon Dunn, Katherine P Himes, Elizabeth E Krans

Abstract readEvaluation Study
In one paragraph

Article in Contraception, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Increasing access to immediate postpartum contraceptive implants: a prospective clinical trial among patients with opioid use disorder.The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception · 2022
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Anupama KothaDepartment of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh, 300 Halket Street, Pittsburgh, PA 15260.
Beatrice A ChenDepartment of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh, 300 Halket Street, Pittsburgh, PA 15260; Magee-Womens Research Institute, 204 Craft Avenue, Pittsburgh, PA 15213.
Lauren LewisDepartment of Obstetrics and Gynecology, Saint Francis Hospital and Medical Center, 114 Woodland St., Hartford, CT 06105.
Shannon DunnMagee-Womens Research Institute, 204 Craft Avenue, Pittsburgh, PA 15213.
Katherine P HimesDepartment of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh, 300 Halket Street, Pittsburgh, PA 15260; Magee-Womens Research Institute, 204 Craft Avenue, Pittsburgh, PA 15213.
Elizabeth E KransDepartment of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh, 300 Halket Street, Pittsburgh, PA 15260; Magee-Womens Research Institute, 204 Craft Avenue, Pittsburgh, PA 15213. Electronic address: kransee@upmc.edu.
Magee-Womens Research Institute · USUniversity of Pittsburgh · USCraft Engineering Associates (United States) · USSaint Francis University · US

Funding

Buprenorphine Assignment in Pregnancy: Objective CriteriaK23DA038789 · NIDA · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI KRANS, ELIZABETH E · 2016 to 2018
$497k
NIDA NIH HHS K23 DA038789
6 · The paper itself

Abstract

backgroundMany women with opioid use disorder (OUD) do not use highly effective postpartum contraception such as long-acting reversible contraception (LARC). We evaluated factors associated with prenatal intent and postpartum receipt of LARC among women receiving medication-assisted treatment (MAT) for OUD. STUDY

designThis was a retrospective cohort study of 791 pregnant women with OUD on MAT who delivered at an academic institution without immediate postpartum LARC services between 2009 and 2012. LARC intent was defined as a documented plan for postpartum LARC during pregnancy and LARC receipt was defined as documentation of LARC placement by 8 weeks postpartum. We organized contraceptive methods into five categories: LARC, female sterilization, short-acting methods, barrier methods and no documented method. Multivariable logistic regression identified characteristics predictive of prenatal LARC intent and postpartum LARC receipt.

resultsAmong 791 pregnant women with OUD on MAT, 275 (34.8%) intended to use postpartum LARC and only 237 (29.9%) attended the postpartum visit. Among 275 women with prenatal LARC intent, 124 (45.1%) attended their postpartum visit and 50 (18.2%) received a postpartum LARC. Prenatal contraceptive counseling (OR 6.67; 95% CI 3.21, 13.89) was positively associated with LARC intent. Conversely, older age (OR 0.95; 95% CI 0.91, 0.98) and private practice provider (OR 0.48; 95% CI 0.32, 0.72) were negatively associated with LARC intent. Although parity was not predictive of LARC intent, primiparous patients (CI 0.49; 95% CI 0.26, 0.97) were less likely to receive postpartum LARC.

conclusionsDiscrepancies exist between prenatal intent and postpartum receipt of LARC among pregnant women with OUD on MAT. Immediate postpartum LARC services may reduce LARC access barriers. IMPLICATIONS: Despite prenatal interest in using LARC, most pregnant women with OUD on MAT did not receive postpartum LARC. The provision of immediate postpartum LARC services may reduce barriers to postpartum LARC receipt such as poor attendance at the postpartum visit.

Indexed as

AdultFemaleHumansIntentionLong-Acting Reversible ContraceptionOpiate Substitution TreatmentOpioid-Related DisordersPatient Acceptance of Health CarePostpartum PeriodPregnancyPrenatal CareRetrospective StudiesYoung AdultLong-acting reversible contraceptionOpioid use disorderPostpartum contraceptionPregnancy

Identifiers

PMID30114393
PMCPMC6289834
OpenAlexW2887884984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.